ArticleJournal of cancer research and clinical oncology2022

Reversing resistance to immune checkpoint inhibitor by adding recombinant human adenovirus type 5 in a patient with small cell lung cancer with promoted immune infiltration: a case report.

Qi Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.